Watch AXSM. Know when insiders buy.
One email the day a filing lands. Free.
AXSM
Axsome Therapeutics, Inc.
156.31
−3.27 −2.05%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
43
WATCH · insiders 25, shorts 60
Insiders, 90 days
−$2.1M
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
3 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $8.2BP/E —DIV YIELD —FCF YIELD -0.88%REV TTM $776.6M +56.9%NET INCOME −$191.6MNET CASH $131.9M52W 127.06 – 255.17SEC XBRL · TTM TO Invalid Date
Who holds it
| Fund | Type | Rank in portfolio | Value | Shares | As of |
|---|---|---|---|---|---|
| Renaissance Technologies | Guru | #255 | $64.1M | 262K | 2026-06-30 |
| PSP Investments | Pension | #198 | $28.4M | 116K | 2026-06-30 |
| Bridgewater Associates (Ray Dalio) | Guru | #267 | $14.2M | 58K | 2026-06-30 |
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
No 13D or 13G filing on AXSM in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.